Longfei Zhao

The paper develops MatWISE, a framework using NLP and ML to discover a biomaterial for renally impaired hyperuricemia, identifying δ-MnO2 as a promising UA-lowering agent.

DRUGSYNC predicts synergistic drug combinations using pre-learned gene expression profiles and a GCN model, achieving high accuracy for unseen drug pairs.

This paper introduces MVAE-DFDPnet, a deep learning model that generates low-dimensional embeddings for drug-protein interactions, achieving better performance than existing methods.